Biodegradable suture development-based albumin composites for tissue engineering applications.

Recent advancements in the field of biomedical engineering have underscored the pivotal role of biodegradable materials in addressing the challenges associated with tissue regeneration therapies. The spectrum of biodegradable materials presently encompasses ceramics, polymers, metals, and composites, each offering distinct advantages for the replacement or repair of compromised human tissues. Despite their utility, these biomaterials are not devoid of limitations, with issues such as suboptimal tissue integration, potential cytotoxicity, and mechanical mismatch (stress shielding) emerging as significant concerns. To mitigate these drawbacks, our research collective has embarked on the development of protein-based composite materials, showcasing enhanced biodegradability and biocompatibility. This study is dedicated to the elaboration and characterization of an innovative suture fabricated from human serum albumin through an extrusion methodology. Employing a suite of analytical techniques-namely tensile testing, scanning electron microscopy (SEM), and thermal gravimetric analysis (TGA)-we endeavored to elucidate the physicochemical attributes of the engineered suture. Additionally, the investigation extends to assessing the influence of integrating biodegradable organic modifiers on the suture's mechanical performance. Preliminary tensile testing has delineated the mechanical profile of the Filament Suture (FS), delineating tensile strengths spanning 1.3 to 9.616 MPa and elongation at break percentages ranging from 11.5 to 146.64%. These findings illuminate the mechanical versatility of the suture, hinting at its applicability across a broad spectrum of medical interventions. Subsequent analyses via SEM and TGA are anticipated to further delineate the suture's morphological features and thermal resilience, thereby enriching our comprehension of its overall performance characteristics. Moreover, the investigation delves into the ramifications of incorporating biodegradable organic constituents on the suture's mechanical integrity. Collectively, the study not only sheds light on the mechanical and thermal dynamics of a novel suture material derived from human serum albumin but also explores the prospective enhancements afforded by the amalgamation of biodegradable organic compounds, thereby broadening the horizon for future biomedical applications.

Effect of using nano-particles of magnesium oxide and titanium dioxide to enhance physical and mechanical properties of hip joint bone cement.

In this work, the effect of adding Magnesium Oxide (MgO) and Titanium Dioxide (TiO2) nanoparticles to enhance the properties of the bone cement used for hip prosthesis fixation. Related to previous work on enhanced bone cement properties utilizing MgO and TiO2, samples of composite bone cement were made using three different ratios (0.5%:1%, 1.5%:1.5%, and 1%:0.5%) w/w of MgO and TiO2 to determine the optimal enhancement ratio. Hardness, compression, and bending tests were calculated to check the mechanical properties of pure and composite bone cement. The surface structure was studied using Fourier transform infrared spectroscopy (FTIR) and Field emission scanning electron microscopy (FE-SEM). Setting temperature, porosity, and degradation were calculated for each specimen ratio to check values matched with the standard range of bone cement. The results demonstrate a slight decrease in porosity up to 2.2% and degradation up to 0.17% with NP-containing composites, as well as acceptable variations in FTIR and setting temperature. The compression strength increased by 2.8% and hardness strength increased by 1.89% on adding 0.5%w/w of MgO and 1.5%w/w TiO2 NPs. Bending strength increases by 0.35% on adding 1.5% w/w of MgO and 0.5% w/w TiO2 NPs, however, SEM scan shows remarkable improvement for surface structure.

Implementation and Evaluation of a Dynamic Neck Brace Rehabilitation Device Prototype.

Rehabilitation assistive devices for head/neck pain treatment cannot allow dynamic changes in position and orientation of the head/neck. Moreover, such devices can neither be used simultaneously nor can they assess the patients' head/neck conditions. This paper aims at designing and implementing a novel dynamic head/neck brace that provides static and dynamic support and/or traction at symmetric and asymmetric positions. This device also provides assessments of the head/neck stiffness for the purpose of fulfilling diagnoses of the head/neck disorders. The device was used and evaluated for its range of motion and its symmetric traction capability using two control modalities. In addition, it was also evaluated in determining the stiffness of the head/neck throughout a simulating mechanical model involved in a set of springs. The device could apply right/left lateral bending to the head/neck ranged -6.97 ± 0.01° to 7.02 ± 0.01° with accuracies of 99.89% and 99.48%, and flexion/extension ranged -8.10 ± 0.02° to 8.12 ± 0.01° with accuracies of 99.57% and 99.42%, respectively, throughout a traction phase of 20 mm. The practical measurements through the symmetric traction tests showed some deviations as compared to that being calculated. Such deviations were greater in flexion/extension rather than the right/left lateral bending. The mean of the obtained error was less than 0.34° for all situations of tests. The accuracies of stiffness measurement of the mechanical model were 99.78% and 99.96%, respectively, throughout performing stair and step tests. The paper presented a novel design of a dynamic head/neck brace that provides support and/or traction to any head/neck positions and capable of evaluating the head/neck stiffness during cervical traction.

A Finite Element-Based Analysis of a Hemodynamics Efficient Flow Stent Suitable for Different Abdominal Aneurysm Shapes.

This research aimed to examine the impact of a proposed flow stent (PFS) on different abdominal artery shapes. For that purpose, a finite element-based model using the computational fluid dynamics (CFD) method is developed. The effect of PFS intervention on the hemodynamic efficiency is estimated by all of the significant criteria used for the evaluation of aneurysm occlusion and possible rupture; the flow velocity, pressure, wall shear stress (WSS), and WSS-related indices. Results showed that PFS intervention preserves the effects of high flowrate and decreases irregular flow recirculation in the sac of the aneurysm. The flow velocity reduction inside the aneurysm sac is in the range of 55% to 80% and the time-averaged wall shear stress (TAWSS) reduction is in the range of 42% to 53% by PFS deployment. The simulation results implies that PFS could heal an aneurysm efficiently with a mechanism that causes the development of thrombus and ultimately leads to aneurysm resorption.

Studying the effect of stent thickness and porosity on post-stent implantation hemodynamics.

This study investigates the effect of stent thickness and stent porosity which are important factors determining the post-treatment intra-aneurysmal hemodynamics. The study uses computational fluid dynamics (CFD) to estimate the hemodynamic behaviour: flow velocity, pressure distributions, time-averaged wall shear stress (TAWSS), oscillatory shear index (OSI), besides relative residence time (RRT) blood flow distribution in a proposed stent and three other commercially available stents. The hemodynamic behaviour is compared between four different cases. In each case, each stent has the specific thickness and porosity values. The results show that the velocity magnitude inside the sac declined in thinner stents and lower porosity stents, TAWSS on the aneurysmal wall declined linearly in lower porosity stents, OSI and RRT increased obviously in thicker stents and higher porosity stents. Finally, the results conclude that the stent with the lowest thickness and porosity has the best performance that leads to post-stent thrombus formation and healing. However, the proposed stent design, a more porous construct, has a higher RRT compared to the used commercially available stents, which helps promote the thrombus growth inside the aneurysm sac.